CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has recently launched its new Time-Lapse Imaging services to assist scientists in a variety of projects, including the study of cell migration in chemotaxis assays or wound healing assays, the identification of stem cells and embryos and their development, and the measurement of cell proliferation over time.
STEMart, a US-based provider of comprehensive services for all phases of medical device development, is pleased to announce that it offers Disinfection Validation Services for reusable medical devices. These services are designed to ensure that products meet FDA requirements for disinfection validation and patient safety.
BOC Sciences, one of the front-runners in chemical material manufacturing and custom services for the full drug product lifecycle, today reported strong growth over the past year in its expanded contract development and manufacturing (CDMO) platform.
CD BioSciences has recently announced the launch of the Hyperspectral Imaging Technology to assist researchers in the detection of biological contaminants of food production at different stages.
Creative Diagnostics recently introduced the Microneutralization Assay Service to support research labs in detecting virus-specific neutralizing antibodies from human and animal sera.
STEMart has recently introduced Bioburden Tissue Testing services for medical applications, including Aerobic Count, Anaerobic Count, Fungi/Mold Count, and Spore Count.
Satisfied Users & 
Approved Press Releases
